awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38946563-34B872C6-DDCE-4FCF-8D8A-348B426F12A4
Q38946563-34B872C6-DDCE-4FCF-8D8A-348B426F12A4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38946563-34B872C6-DDCE-4FCF-8D8A-348B426F12A4
Evaluation of the immunogenicity of the dabigatran reversal agent idarucizumab during Phase I studies.
P2860
Q38946563-34B872C6-DDCE-4FCF-8D8A-348B426F12A4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38946563-34B872C6-DDCE-4FCF-8D8A-348B426F12A4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3dc1377da6ef5745b3194a8cb59bea1150c24ea4
P2860
Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.